Literature DB >> 23864196

Using small-for-size grafts in living donor liver transplantation recipients with high MELD scores should not be considered a contraindication.

Hongyu Li1, Bo Li.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23864196     DOI： 10.1007/s10620-013-2797-4

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  4 in total

1.  A high model for end-stage liver disease score should not be considered a contraindication to living donor liver transplantation.

Authors:  K-S Poon; T-H Chen; L-B Jeng; H-R Yang; P-C Li; C-C Lee; C-C Yeh; H-C Lai; W-P Su; C Y Peng; Y-F Chen; Y-J Ho; P-P Tsai
Journal:  Transplant Proc       Date:  2012-03       Impact factor: 1.066

Review 2.  Small-for-size graft problems in adult-to-adult living-donor liver transplantation.

Authors:  Yasuhiko Sugawara; Masatoshi Makuuchi
Journal:  Transplantation       Date:  2003-02-15       Impact factor: 4.939

3.  Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.

Authors:  Nam-Joon Yi; Kyung-Suk Suh; Hae Won Lee; Woo Young Shin; Juhyun Kim; Won Kim; Yoon Jun Kim; Jung-Hwan Yoon; Hyo-Suk Lee; Kuhn Uk Lee
Journal:  Liver Transpl       Date:  2009-05       Impact factor: 5.799

4.  Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.

Authors:  Paul H Hayashi; Lisa Forman; Tracy Steinberg; Thomas Bak; Michael Wachs; Marcelo Kugelmas; Gregory T Everson; Igal Kam; James F Trotter
Journal:  Liver Transpl       Date:  2003-07       Impact factor: 5.799
  4 in total
  2 in total

1.  Small for size syndrome difficult dilemma: Lessons from 10 years single centre experience in living donor liver transplantation.

Authors:  Hany Shoreem; Emad Hamdy Gad; Hosam Soliman; Osama Hegazy; Sherif Saleh; Hazem Zakaria; Eslam Ayoub; Yasmin Kamel; Kalid Abouelella; Tarek Ibrahim; Ibrahim Marawan
Journal:  World J Hepatol       Date:  2017-07-28

2.  Outcomes of hemi- versus whole liver transplantation in patients from mainland china with high model for end-stage liver disease scores: a matched analysis.

Authors:  LingXiang Kong; Tao Lv; Li Jiang; Jian Yang; Jiayin Yang
Journal:  BMC Surg       Date:  2020-11-20       Impact factor: 2.102
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.